Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Sessions to Check Out During the 2018 ACR/ARHP Annual Meeting

  |  

Other sessions include:

  • ACR/ARHP: My Chromosomes & Me: Talk to Patients About Consumer Genetic Tests, 1–2 p.m.;
  • Study Group: Developing Support & Education Programs for People with Rheumatic Diseases, 1–2 p.m.; and
  • ARHP: The Aging Foot in Rheumatology, 4:30–6 p.m.

This year’s ACR/ARHP Annual Meeting offers top-notch rheumatology education, as well as opportunities for networking, collaboration and professional development. For the latest program information and speaker bios, check out the 2018 ACR/ARHP Annual Meeting Online Program.

ADVERTISEMENT
SCROLL TO CONTINUE

Stay Organized with the Annual Meeting App

This year’s meeting offers more than 450 sessions. Attendees can keep track of the daily events by using the 2018 ACR/ARHP Annual Meeting App. With the app, users can easily access meeting sessions, abstracts, speaker bios and exhibitor information.

Available online and on iOS or Android devices, the app allows users to personalize their schedules, take notes, engage in social media interaction and more.

Registration Is Open

Don’t miss out on the top-notch rheumatology education, networking and professional development that will be offered at the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago.

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    Reading Rheum

    Handpicked Reviews of Contemporary Literature

    Should Hydroxychloroquine Level Testing Be Standard Care in Lupus?

    The Johns Hopkins Lupus Center, Baltimore, has described its experience using hydroxychloroquine (HCQ) levels.1 Forty-four percent of its patients had levels below 500 ng/mL (partial nonadherence); 13% were severely nonadherent (<200 ng/mL). They were shown their results and educated on HCQ adherence. Adherence then improved to 80%; those with lower HCQ levels had higher disease…

    Rheumatologists Debate Hydroxychloroquine Dosing Guidelines for Lupus

    CHICAGO—The correct dosing of hydroxychloroquine (HCQ) for systemic lupus erythematosus (SLE) is a concern of all rheumatologists. Petros Efthimiou, MD, clinical professor of medicine at New York University, New York City, opened the Great Debate of the 2018 ACR/ARHP Annual Meeting by stating, “Today, we will be discussing a critical clinical problem that affects everyone’s…

    New Study Probes Hydroxychloroquine Adherence During Pregnancy

    Hydroxychloroquine (HCQ) is nearly universally recommended for pregnant patients with systemic lupus erythematosus (SLE) to reduce lupus disease activity and adverse outcomes in pregnancy.1-3 Yet despite strong evidence supporting its benefits, HCQ appears underutilized, with several studies suggesting fewer than half of all women with lupus take this medication during pregnancy.4 How accurately these results…